Showing 2,758 results

Filters Content type: News, Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Confidentiality, consent & medical ethics

“Why are we being used like guinea pigs?” Transgender women’s mistrust of PrEP research

News
20 October 2021
Vaginal rings & topical PrEP

The Dapivirine Vaginal Ring: Gone far and far to go

Editor's pick
AVAC
17 October 2021
PrEP programmes & uptake

US: Racial Factors May Affect PrEP Discussions With Black Women

Editor's pick
Medscape (requires free registration)
10 October 2021
PrEP science

Islatravir Subdermal Implant for HIV PrEP Has Promising Phase 1 Trial

Editor's pick
Contagion Live
7 October 2021
Sex workers

More money, trust, and control: HIV self-testing and PrEP empowers sex workers and their partners in Uganda

News
6 October 2021
Weight gain & lipodystrophy

Older version of tenofovir used as PrEP linked to weight loss

News
5 October 2021
Combatting stigma

Ending PrEP Stigma: Researcher Calls For Integrating HIV Services Into Primary Health Care

Editor's pick
TheBodyPro
4 October 2021
PrEP science

Most switches to Descovy PrEP are probably unnecessary and some may be harmful

News
1 October 2021
PrEP programmes & uptake

Is There a PrEP-to-Primary Care Pipeline?

Editor's pick
POZ
28 September 2021
Injectable & long-acting PrEP

FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV

Editor's pick
ViiV Healthcare press release
28 September 2021
PrEP programmes & uptake

Don’t Underestimate the Benefit of HIV PrEP for Trans Women

Editor's pick
POZ
22 September 2021
Sex workers

Successful PrEP interventions in marginalised communities: the Ashodaya PrEP Project

News
22 September 2021
Kidney problems

People over 50 years old or with existing kidney dysfunction are more likely to get kidney damage when using tenofovir disoproxil-based PrEP

News
21 September 2021
PrEP programmes & uptake

US: States Late to Adopt PrEP Risk Falling Further Behind

Editor's pick
American Journal of Managed Care
20 September 2021
New & experimental HIV treatments

Exavir Therapeutics announces publication of preclinical data for novel tenofovir prodrug, XVIR-210, in Nature Communications, demonstrating long-acting exposures sufficient for antiviral activity against HIV and HBV

Editor's pick
GlobeNewswire
20 September 2021
PrEP science

One dose of TAF every three days gets more drug into cells than a daily dose of TDF

News
17 September 2021
PrEP programmes & uptake

People Who Might Benefit Most From PrEP Too Often Stop Taking It. Can Targeted Strategies Help?

Editor's pick
TheBodyPro
13 September 2021
PrEP science

First-in-Class NRTTI Demonstrates Potential as Long-Acting Oral PrEP Against HIV

Editor's pick
Contagion Live
13 September 2021
Injectable & long-acting PrEP

Editorial: HIV prevention injection should be fast-tracked like COVID-19 vaccines

Editor's pick
Spotlight
12 September 2021
PrEP programmes & uptake

Access to Care is Key to PrEP Initiation, But More Is Needed to Mitigate Attrition

Editor's pick
Contagion Live
8 September 2021
PrEP science

Truvada or Descovy for PrEP? Your Lab Work May Tell You

Editor's pick
POZ
8 September 2021
Injectable & long-acting PrEP

In-depth: What will it take to bring HIV prevention injections to South Africa’s clinics?

Editor's pick
Spotlight
1 September 2021
PrEP programmes & uptake

How to speed-up PrEP rollout in sub-Saharan Africa

Editor's pick
Avert
31 August 2021
PrEP programmes & uptake

Creating Greater PrEP Access with Large Public Health Goals and Local Service Models

Editor's pick
Contagion Live (Video)
21 August 2021